Promising Emerging Classes of Therapies in Non-Small Cell Lung Cancer
14 Visualizações
• 07/14/23
0
0
Embutir
administrator
Assinantes
David Gandara, MD, Corey J. Langer, MD, Anne S. Tsao, MD, Alan B. Sandler, MD, and Mark A. Socinski, MD, each provide their opinion on the most promising emerging class of therapeutics in non-small cell lung cancer (NSCLC).
More from this Peer Exchange discussion: http://www.onclive.com/peer-ex....change/nsclc-advance
Mostre mais
Comentários do Facebook
SORT BY-
Melhores Comentários
-
Últimos Comentários